Published in PLoS One on August 17, 2011
Serum hyaluronan levels increase with the total number of osteoarthritic joints and are strongly associated with the presence of knee and finger osteoarthritis. Int Orthop (2013) 0.90
Protection effect of kallistatin on carbon tetrachloride-induced liver fibrosis in rats via antioxidative stress. PLoS One (2014) 0.87
Hyaluronic Acid: from biochemical characteristics to its clinical translation in assessment of liver fibrosis. Hepat Mon (2013) 0.87
Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol (2015) 0.84
Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children. PLoS One (2013) 0.82
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C. Hepat Mon (2013) 0.79
Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia. Hepat Res Treat (2014) 0.79
Serum hyaluronic acid concentration in Fontan circulation: correlation with hepatic function and portal vein hemodynamics. Pediatr Cardiol (2013) 0.78
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World J Gastroenterol (2016) 0.77
Hyaluronic acid concentration in liver diseases. Clin Exp Med (2015) 0.77
Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C. Medicine (Baltimore) (2016) 0.77
Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children. Mem Inst Oswaldo Cruz (2013) 0.76
A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts. J Am Med Inform Assoc (2016) 0.75
Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies. Clujul Med (2016) 0.75
Mechanisms of hepatic fibrogenesis. Gastroenterology (2008) 11.98
Liver biopsy. N Engl J Med (2001) 9.91
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol (2002) 8.21
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology (2002) 6.92
Liver fibrosis -- from bench to bedside. J Hepatol (2003) 5.80
Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol (2003) 5.17
Evaluation of liver fibrosis: a concise review. Am J Gastroenterol (2004) 4.37
Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology (2002) 4.34
Noninvasive assessment of liver fibrosis. Hepatology (2010) 3.86
Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med (2006) 3.84
The natural history of hepatitis C virus (HCV) infection. Int J Med Sci (2006) 3.13
Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem (2002) 2.88
Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut (2010) 2.70
Host genetic factors influence disease progression in chronic hepatitis C. Hepatology (2000) 2.26
Diagnosis and quantitation of fibrosis. Gastroenterology (2008) 2.20
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology (2008) 2.02
Liver biopsy:complications and risk factors. World J Gastroenterol (1999) 1.91
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem (2007) 1.84
The role of liver biopsy in chronic hepatitis C. Hepatology (2002) 1.77
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol (2006) 1.63
Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol (2004) 1.60
Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein. J Hepatol (2010) 1.58
The cell biology of liver fibrogenesis - an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts. Cell Tissue Res (1998) 1.58
Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases. J Viral Hepat (2007) 1.54
Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology (2002) 1.51
Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol (2004) 1.49
Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Aliment Pharmacol Ther (2007) 1.38
Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C. J Viral Hepat (2011) 1.36
Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease. World J Gastroenterol (2005) 1.19
Transforming growth factor-beta 1 in chronic hepatitis C. J Viral Hepat (1997) 1.18
Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis (2003) 1.18
Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. J Med Virol (2004) 1.16
Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology (1998) 1.14
Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy? Gastroenterology (2005) 1.13
Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. J Gastroenterol Hepatol (2003) 1.09
Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan. Hepatology (1997) 1.05
Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. Transl Res (2010) 1.02
Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C. Aliment Pharmacol Ther (2010) 1.02
Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection. J Pediatr Gastroenterol Nutr (2005) 1.01
Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest. Eur J Gastroenterol Hepatol (2010) 0.98
Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection? Liver Int (2008) 0.97
Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis. Clin Gastroenterol Hepatol (2008) 0.96
Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients? BMC Infect Dis (2010) 0.90
Serum laminin-2 and hyaluronan predict severe liver fibrosis in children with chronic hepatitis B. Hepatology (2004) 0.89
Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection. J Viral Hepat (2009) 0.88
Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection. J Viral Hepat (2009) 0.88
Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med (2011) 0.88
Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease. J Pediatr Gastroenterol Nutr (2006) 0.87
Mechanical stretch induces matrix metalloproteinase 1 production in human hepatic stellate cells. Pathophysiology (2004) 0.86
Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol (2006) 0.84
Hepatitis C virus infection in infants and children from Argentina. J Clin Microbiol (2004) 0.84
Non-invasive assessment of chronic liver and gastric diseases. Clin Chim Acta (2007) 0.82
Determination of serum fibrosis index in patients with chronic hepatitis and its relationship to histological activity index. Saudi Med J (2009) 0.81
Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infection. Gastroenterol Clin Biol (2009) 0.80
Elevated TGF-β1 levels might protect HCV/ HIV-coinfected patients from liver fibrosis. Eur J Clin Invest (2010) 0.79
The role of plasma transforming growth factor beta-1 in the development of fibrosis in patient with HCV related steatohepatitis. J Egypt Soc Parasitol (2010) 0.78
[Statement of the Argentinian Concensus on Hepatitis C 2007]. Acta Gastroenterol Latinoam (2008) 0.77
Serum hyaluronic acid concentrations in children with cirrhosis. Indian J Gastroenterol (2004) 0.76
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med (2006) 7.35
Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. Gastroenterology (2007) 2.11
Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res (2002) 1.88
Liver transplantation: the last measure in the treatment of bile duct injuries. World J Surg (2008) 1.84
Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B. Clin Gastroenterol Hepatol (2010) 1.60
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report. Liver Int (2009) 1.46
Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B. Gastroenterology (2012) 1.20
Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. J Virol (2006) 1.06
Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study. Liver Int (2008) 1.05
[Hepatic tuberculoma: presentation of cases and review of the literature]. Acta Gastroenterol Latinoam (2004) 0.92
Endoscopic management of biliary complications after adult living-donor versus deceased-donor liver transplantation. Transplantation (2009) 0.92
Transmission of T. cruzi infection via liver transplantation to a nonreactive recipient for Chagas' disease. Liver Transpl (2005) 0.90
Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma. PLoS One (2010) 0.90
EBNA1 sequences in Argentinean pediatric acute and latent Epstein-Barr virus infection reflect circulation of novel South American variants. J Med Virol (2010) 0.88
Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites. Liver Int (2012) 0.88
Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis. J Med Virol (2010) 0.88
Genetic variation in interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin. Ann Hepatol (2011) 0.87
Characterization of the basal core promoter and precore regions in anti-HBe-positive inactive carriers of hepatitis B virus. Int J Infect Dis (2011) 0.86
Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment. Int J Cancer (2012) 0.84
Phylogenetic analysis of previously nontypeable hepatitis C virus isolates from Argentina. J Clin Microbiol (2006) 0.84
Hepatitis C virus infection in infants and children from Argentina. J Clin Microbiol (2004) 0.84
Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas. J Med Virol (2007) 0.84
Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir. Antivir Ther (2013) 0.84
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B. Liver Transpl (2013) 0.83
Hepatitis C virus isolates from Argentina disclose a novel genotype 1-associated restriction pattern. J Clin Microbiol (2004) 0.83
Dynamic changes in viral population structure and compartmentalization during chronic hepatitis C virus infection in children. Virology (2013) 0.83
Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children. PLoS One (2013) 0.82
Combined extended haemodialysis with single-pass albumin dialysis (SPAED). Nephrol Dial Transplant (2007) 0.82
Granulomatous nephritis associated with R334Q mutation in NOD2. J Rheumatol (2007) 0.82
Full-length genome characterization of hepatitis B virus genotype H strain isolated from serum samples collected from two chronically infected patients in Argentina. J Clin Microbiol (2009) 0.82
Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma--another point of view. Breast Cancer Res (2003) 0.82
Hereditary nonpolyposis colorectal cancer (Lynch Syndrome) in Argentina: report from a referral hospital register. Dis Colon Rectum (2007) 0.81
Epstein-Barr virus BZLF1 gene promoter variants in pediatric patients with acute infectious mononucleosis: its comparison with pediatric lymphomas. J Med Virol (2009) 0.81
Comparison of Epstein-Barr virus presence in Hodgkin lymphoma in pediatric versus adult Argentine patients. Arch Pathol Lab Med (2003) 0.80
Epstein Barr virus-associated lymphoma in HIV-infected children. Pathol Res Pract (2002) 0.80
Epstein-Barr virus associated with primary CNS lymphoma and disseminated BCG infection in a child with AIDS. Int J Infect Dis (2005) 0.80
The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis. J Clin Immunol (2012) 0.80
Assessment of Epstein-Barr virus association with pediatric non-hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina. Arch Pathol Lab Med (2002) 0.80
Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms. J Clin Microbiol (2012) 0.79
[Clinical course of inflammatory bowel disease in patients transplanted for primary sclerosing cholangitis]. Acta Gastroenterol Latinoam (2008) 0.78
Living donor liver transplantation in high-risk vs. low-risk patients: optimization using statistical models. Liver Transpl (2006) 0.78
Cell cycle characteristics and Epstein-Barr virus are differentially associated with aggressive and non-aggressive subsets of Hodgkin lymphoma in pediatric patients. Leuk Lymphoma (2010) 0.78
Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome. J Pediatr Hematol Oncol (2008) 0.78
Low frequency of Epstein Barr virus association and high frequency of p53 overexpression in an Argentinean pediatric T-cell lymphoma series. Pediatr Dev Pathol (2009) 0.77
[Argentine consensus on hepatitis C 2013]. Acta Gastroenterol Latinoam (2014) 0.77
[Recommendations for the treatment of chronic genotype 1 hepatitis C virus infection]. Acta Gastroenterol Latinoam (2012) 0.76
Epstein-Barr virus (EBV) association and latency profile in pediatric Burkitt's lymphoma: experience of a single institution in Argentina. J Med Virol (2013) 0.76
Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients. Hum Pathol (2008) 0.76
Caffeic Acid Phenylethyl Ester and MG-132 Have Apoptotic and Antiproliferative Effects on Leukemic Cells But Not on Normal Mononuclear Cells. Transl Oncol (2009) 0.76
No Influence of bcl-2, p53, and p21waf1 protein expression on the outcome of pediatric Hodgkin lymphomas. J Pediatr Hematol Oncol (2006) 0.76
Colorectal cancer staging: reappraisal of N/PN classification. Dis Colon Rectum (2004) 0.76
LMP1 promoter sequence analysis in Epstein Barr virus pediatric infection reveals preferential circulation of B95.8 related variants in Argentina. Infect Genet Evol (2013) 0.76
[Twenty-four weeks therapy with peginterferon alfa-2a could be similar to 48 weeks therapy in patients with HBeAg positive chronic hepatitis B and good predictors of response: results of a pilot study]. Acta Gastroenterol Latinoam (2009) 0.75
[Image in gastric antrum]. Acta Gastroenterol Latinoam (2012) 0.75
[Transient elastography: noninvasive assessment of liver fibrosis. Report of 1,000 cases in Argentina]. Acta Gastroenterol Latinoam (2012) 0.75
Diagnosis of patients with suspected chronic hepatitis C infection. Ann Hepatol (2010) 0.75
[Regenerative nodular hyperplasia in HIV]. Acta Gastroenterol Latinoam (2011) 0.75
[Organ transplants in HIV infected patients. Update and recommendations]. Medicina (B Aires) (2011) 0.75
[Immunohistochemical expression and microsatellite instability in Lynch syndrome]. Medicina (B Aires) (2007) 0.75
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates. Transplantation (2017) 0.75
Germline TP53 mutations and single nucleotide polymorphisms in children. Medicina (B Aires) (2009) 0.75
[Natural history of hepatitis C in patients HIV-HCV monoinfected and co-infected]. Acta Gastroenterol Latinoam (2006) 0.75
International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS. Transplantation (2017) 0.75
Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease. Pediatr Blood Cancer (2005) 0.75
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients. Transplantation (2017) 0.75
Early predictors of renal dysfunction in cirrhotic patients after liver transplantation. Acta Gastroenterol Latinoam (2014) 0.75
Immunohistochemical expression of p53, bcl-2, and p21waf1 in 48 Argentinean children with non-Hodgkin lymphoma. Appl Immunohistochem Mol Morphol (2006) 0.75
[Diagnosis, treatment and evolution of the Budd-Chiari syndrome: a single center experience]. Acta Gastroenterol Latinoam (2010) 0.75
[Latin American guideline for the management of chronic hepatitis B]. Acta Gastroenterol Latinoam (2011) 0.75